Position in ASND
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$28,240,606
+$16,150,965 QoQ
Shares Held
123,467
+117.8% QoQ
Ownership
0.188%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ASND Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Chevy Chase Trust Holdings, LLC holds $389,793,054 across 7 Biotechnology names. ASND ranks #3 (7.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
407,615 | $182,016,401 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
205,833 | $159,034,808 | |
| 3 | ASND |
Ascendis Pharma A/S
This page
|
123,467 | $28,240,606 | |
| 4 | MRNA |
Moderna, Inc.
|
171,318 | $8,702,954 | |
| 5 | INCY |
Incyte Corp
|
82,356 | $7,751,346 | |
| 6 | TECH |
BIO-TECHNE Corp
|
77,075 | $4,027,939 | |
| 7 | CRBU |
Caribou Biosciences, Inc.
|
10,000 | $19,000 |
All Filings in ASND
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $28,240,606 | 123,467 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $12,089,641 | 56,695 | Shares | Defined | 2026-02-13 | |
| No filing history on record for this holder in this stock. | ||||||